BMRN
Biomarin Pharmaceutical Inc
61.40$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +228.6% | -25.7% | +123.3% | -35.6% | +131.7% | -9.1% | -16.2% | +137.3% | +75.9% | +11.2% | +1.2% | +37.7% | +3.4% | +20.1% | +43.1% | +11.0% | +49.7% | +7.9% | +15.1% | -4.4% | +5.9% | +24.7% | +2.7% | +6.2% | +7.3% | +2.2% | +8.7% | |
| – | +418.9% | -32.9% | +207.1% | -40.7% | +177.9% | -62.1% | -19.2% | +384.8% | +92.8% | +14.5% | -36.6% | +7.8% | -6.8% | +58.3% | +53.0% | +25.3% | -23.6% | +30.5% | +55.2% | -6.8% | -5.5% | +20.6% | -2.9% | +21.0% | +7.4% | +9.3% | +22.3% | |
| – | +149.1% | -29.4% | -24.2% | +168.5% | +260.9% | -89.2% | +191.2% | +134.1% | +156.1% | -2.4% | -25.0% | -47.3% | -47.5% | +290.1% | +215.1% | +53.9% | -54.6% | +2.8% | +46.5% | -17.4% | -11.4% | +48.4% | -9.5% | +23.4% | +4.2% | +24.9% | +39.1% | |
| – | +570.1% | -36.2% | +226.1% | -43.6% | +178.9% | -76.3% | -2.1% | +504.4% | +102.7% | -4.4% | -46.3% | -8.8% | -28.8% | +131.0% | +74.1% | +20.4% | -37.3% | +33.3% | +76.8% | -22.3% | -30.5% | +41.3% | -4.8% | +27.4% | -16.9% | +6.0% | +37.2% | |
| – | +252.3% | +19.0% | +5.5% | – | – | – | +71.3% | +111.7% | +15.7% | +219.9% | +48.5% | +7.4% | +33.6% | -5.7% | +18.6% | +11.7% | +14.2% | +30.5% | +21.4% | +31.1% | +10.1% | +18.8% | -16.7% | +23.5% | +37.4% | +4.2% | +37.5% | |
| – | +576.0% | -35.5% | – | – | – | – | +370.6% | +130.1% | +29.4% | +125.5% | +7.5% | +39.5% | +18.6% | -1.1% | +26.3% | +22.7% | +36.2% | +30.7% | +34.0% | +11.6% | +28.1% | +2.7% | +11.2% | +15.1% | +23.8% | +11.3% | +5.4% | |
| – | – | – | +57.2% | -13.4% | -10.8% | +69.0% | -12.2% | +48.6% | +38.5% | +62.7% | +59.3% | +11.4% | +21.2% | +5.8% | +12.2% | +63.9% | +34.5% | +13.4% | +12.3% | +5.8% | +6.6% | +2.1% | +0.3% | +7.6% | – | – | – | |
| – | – | – | – | – | – | – | -52.8% | +0.0% | +0.0% | +0.0% | +11.6% | +125.0% | -3.4% | +0.0% | +5.3% | +0.0% | +263.2% | +0.0% | +0.0% | +0.0% | +0.0% | -0.4% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.0% | -14.0% | – | – | – | – | +122.2% | -68.1% | -17.7% | -20.5% | +437.3% | +152.9% | +73.9% | -9.6% | +0.1% | -4.0% | +336.8% | -19.0% | -6.5% | -5.0% | -7.2% | -8.6% | -6.9% | -12.9% | -13.0% | -13.4% | -16.2% | |
| – | +145.1% | +34.2% | +76.7% | -1.5% | +1,047.1% | +117.3% | -9.4% | +26.7% | +81.6% | +0.4% | -5.6% | -8.3% | -2.3% | +3.7% | +63.4% | +6.6% | +38.0% | -5.4% | +45.1% | -20.0% | +7.4% | +11.1% | -0.5% | +2.3% | +6.7% | -29.6% | +13.2% | |
| – | +154.4% | +35.3% | +20.6% | -17.5% | +87.2% | +446.7% | -42.4% | +14.1% | +33.7% | +111.4% | -39.9% | +7.3% | +12.3% | +81.1% | +7.5% | +28.6% | +89.0% | -1.4% | +85.9% | -35.9% | +78.2% | -47.2% | +9.6% | +9.1% | +99.9% | -48.4% | +25.0% | |
| – | – | +3.8% | +5,792.6% | – | – | – | -73.5% | -40.1% | -7.0% | +2,142.5% | – | – | – | – | – | – | +3.0% | -96.6% | +1,505.8% | – | – | -96.8% | -11.0% | -0.9% | +4,744.9% | -95.4% | -62.4% | |
| – | +121.1% | +53.4% | -9.8% | -8.3% | +156.9% | +169.8% | -98.2% | +372.1% | -48.8% | +4,934.3% | -87.1% | -34.5% | +628.2% | +86.1% | +41.9% | +147.4% | +66.5% | -51.2% | -12.9% | +24.6% | +16.1% | -20.6% | +0.8% | +19.8% | +36.4% | -25.4% | +32.9% | |
| – | – | – | +6,973.2% | -14.6% | +3,614.8% | +81.5% | -6.6% | +37.4% | +92.8% | -11.8% | 0.0% | -24.1% | -7.7% | -6.7% | +101.8% | +0.4% | +0.7% | -0.2% | +23.1% | +2.1% | -41.4% | +121.1% | +0.4% | +0.4% | -45.2% | +0.3% | +0.3% | |
| – | +234.6% | -28.9% | +127.9% | -38.2% | +19.6% | -157.7% | – | – | +59.4% | +47.4% | +16.4% | +122.6% | +7.8% | +31.4% | +32.0% | +13.9% | +57.1% | +15.2% | +1.5% | +5.7% | +5.2% | +31.5% | +4.0% | +7.8% | +7.6% | +14.3% | +7.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +33.2% | +19.8% | +14.6% | +29.7% | +16.6% | +3.6% | +7.0% | +22.9% | +13.4% | +8.0% | -3.2% | +25.3% | -10.8% | +7.3% | +14.5% | +6.2% | +9.3% | +3.9% | +4.9% | +1.6% | +1.0% | +7.1% | -4.6% | +3.3% | +1.4% | +2.7% | +0.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.